Thomas Zink is SVP & CMO at Emergent BioSolutions Inc. (EBS). They have made 1 open-market trade across 1 company since 2007, most recently 2007-05-18.
CIK 0001380718
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10K since 2007, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EBS | 1,000 | $6K |
Shares reported on the most recent Form 4, priced at the 2007-05-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EBS | BUY | 2007-05-17 | 2007-05-21 | $10.50 | $10K | -12.7% | -2.9% | -2.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.